Caroline Corbel is a post-doctoral researcher at IRDL, France, since 2013. She received her PhD in Biology from the University of Rennes1 in 2011, on the research of new anticancer agents acting by protein-protein interaction inhibition. From 2011 to 2013, she performed postdoctoral researches at the Neuroscience Research Institute, University of California, USA, in the team of Dr K. Kosik. She worked on the developmental attenuation of NMDA receptor subunit expression by microRNAs. Then, she joined the Pr O. Sire’s team in Vannes to focus on CDK5, an attractive target to discover new therapeutic treatments: CDK5 kinase activity is implicated in neurodegenerative diseases and cancers.